| Authors: |
Holmes FA; Texas Oncology, P.A., US Oncology Research, Houston, TX, USA. Electronic address: faholmesmd@icloud.com., Moy B; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Delaloge S; Institut Gustave Roussy, Villejuif, France., Chia SKL; BC Cancer Agency, Vancouver, BC, Canada., Ejlertsen B; Rigshospitalet, Copenhagen, Denmark., Mansi J; Guy's and St Thomas Hospital NHS Foundation Trust and Biomedical Research Centre, King's College, London, United Kingdom., Iwata H; Aichi Cancer Center, Chikusa-ku, Nagoya, Japan., Gnant M; Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria., Buyse M; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Barrios CH; Hospital São Lucas, PUCRS, Porto Alegre, Brazil., Silovski T; Department of Oncology, UHC Zagreb, Zagreb, Croatia., Šeparović R; University Hospital for Tumors, University Hospital Center 'Sestre Milosrdnice', Zagreb, Croatia., Bashford A; Auckland Hospital, Auckland, New Zealand., Zotano AG; Instituto Valenciano de Oncologia, València, Spain., Denduluri N; Virginia Cancer Specialists, US Oncology Research, Arlington, VA, USA., Patt D; Texas Oncology - Round Rock, US Oncology Research, Austin, TX, USA., Gokmen E; Ege University Faculty of Medicine, Izmir, Turkey., Gore I; Alabama Oncology, Birmingham, AL, USA., Smith JW 2nd; Northwest Cancer Specialists, P.C., US Oncology Research, Vancouver, VA, USA., Loibl S; Center for Hematology and Oncology Bethanien, Frankfurt, Germany and German Breast Group, Neu-Isenburg, Germany., Masuda N; Department of Breast and Endocrine Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan., Tomašević Z; Daily Chemotherapy Hospital, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Petráková K; Masaryk Memorial Cancer Institute, Brno, Czech Republic., DiPrimeo D; Puma Biotechnology Inc., Los Angeles, CA, USA., Wong A; Puma Biotechnology Inc., Los Angeles, CA, USA., Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM, Universidad Complutense, Madrid, Spain., Chan A; Breast Cancer Research Centre-WA & Curtin University, Perth, Australia. |